Illimis Therapeutics

Korea - Seoul

Biotechnology

Focus: Biologics based on a chimeric fusion protein platform

Illimis Therapeutics is a life sciences company focused on Biologics based on a chimeric fusion protein platform.

Funding Stage

SERIES B

Open Jobs

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2022

Publications: 2 in PubMed